Podcasts

Enjoy ASPC's newly launched podcast "The Heart of Prevention" available on Apple, Spotify, and Amazon.

The Heart of Prevention


ASPC also partners with the CardioNerds on a variety of prevention-related topics. Below is a list of all of the episodes currently available. 

ATTR-CM Series

This newly launched series provides a comprehensive overview of transthyretin (ATTR) cardiac amyloidosis, a complex and rapidly evolving disease process. The discussion cover the key red flags for cardiac amyloidosis, the diagnostic pathway, and the implications of hereditary versus wild-type ATTR. Importantly, the episodes delve into the current and emerging therapies for ATTR, including stabilizers, gene silencers, and promising treatments like CRISPR-Cas9 and antibody-based approaches.

ATTR-CM: The Biology of Transthyretin Amyloid Cardiomyopathy 


Cardio-Rheumatology Series

The CardioNerds Cardiovascular Prevention Series has delved into the world of inflammation and its role in Cardiovascular Disease. Inflammation is involved both in the pathogenesis and progression of atherosclerosis. Inflammation may be the inciting factor in atherosclerosis, or it may amplify the process driven primarily by other risk factors. Therefore, treating the comorbidities and traditional CVD contributors is key to reducing the vicious inflammatory cycle. This series will take us through it all! It is supported by and unrestricted educational sponsorship from Agepha Pharma. All CardioNerds content is planned, produced, and reviewed solely by CardioNerds.

Cardio-Rheumatology: The Role of Inflammation in Cardiovascular Disease with Dr. Antonio Abbate

Cardio-Rheumatology: Deciphering Cardiovascular Risk in Patients with Rheumatologic Conditions with Dr. Brittany Weber and Dr. Michael Garshick

Cardio-Rheumatology: Targeting Inflammation for Cardiovascular Risk Reduction with Dr. Paul Ridker

Cardio-Rheumatology: Treating Inflammation and Real-World Implementation of Therapies with Dr. Brittany Weber and Dr. Michael Garshick


SGLT Inhibition Series

The CardioNerds Cardiovascular Prevention Series brings us into the world of SGLT inhibitors. Initially developed as antidiabetic medications, SGLT inhibitors have been shown to have beneficial effects on cardiovascular and renal outcomes. These benefits result from their on-target glucosuric effects and additional off-target effects. This series will guide us through a comprehensive mechanism for Cardiovascular Disease (CVD) prevention and heart failure management, supported by unrestricted educational sponsorship from Lexicon. All CardioNerds content is planned, produced, and reviewed solely by CardioNerds.

SGLT Inhibitors: The Biology of SGLT Inhibition with Dr. Katherine Tuttle

SGLT Inhibitors: The Data Supporting SGLT Inhibition with Dr. Muthiah Vaduganathan

SGLT Inhibitors: Clinical Implementation of SGLT Inhibitors with Dr. Alison Bailey


Obesity and GLP-1 RAs

The CardioNerds Cardiovascular Prevention Series dives into Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs). This class of medications is becoming a household name, not only for their implications for weight loss but also for their effect on cardiovascular disease. This series also highlights the impact of obesity on cardiovascular disease risk, differential risk in specific populations, and effective strategies for counseling patients. This series is supported by unrestricted educational sponsorship from Novo Nordisk. All CardioNerds content is planned, produced, and reviewed solely by CardioNerds.

GLP-1 Agonists: Mechanisms to Applications with Dr. Dennis Bruemmer

Obesity: Obesity & Cardiovascular Disease Risk with Dr. Jaime Almandoz

Obesity: Lifestyle & Pharmacologic Management of Obesity with Dr. Ambarish Pandey

GLP-1 Agonists: Diving into the Data with Dr. Darren McGuire

GLP-1 Agonists: Clinical Implementation of GLP-1 Receptor Agonists with Dr. Neha Pagidapati

Obesity: Procedural Management of Obesity with Dr. Steve Nissen


Cardiovascular Genomics

The CardioNerds Cardiovascular Genomics series is a multi-institutional collaboration made possible by contributions of stellar fellow leads and expert faculty from several programs. The field of Cardiovascular Genomics has advanced significantly over the past two decades, having a profound clinical impact and altering the perception of the role and scope of genetic testing in various cardiovascular domains.  This series is supported by unrestricted educational sponsorship from Illumina, Inc. All CardioNerds content is planned, produced, and reviewed solely by CardioNerds.

Episode 244. Cardiovascular Genomics: Intro to Cardiovascular Genetics in Electrophysiology with Dr. James Daubert

Episode 246. Cardiovascular Genomics: Genetic Counseling & Family Screening in Arrhythmogenic Cardiomyopathies with Dr. Allison Hays and Dr. Cindy James

Episode 248. Cardiovascular Genomics: Frontiers in Clinical Genetics in Cardiovascular Prevention with Dr. Pradeep Natarajan


Lipid Series

The CardioNerds Lipid Series is a comprehensive series led by series co-chairs Dr. Rick Ferraro, cardiology fellow at The Johns Hopkins Hospital, and Dr. Tommy Das, cardiology fellow at The Cleveland Clinic, and produced in collaboration with the American Society for Preventive Cardiology (ASPC). This series has been made possible by unrestricted support from Amgen and Amarin.

131. Lipids: LDL Physiology & Function with Dr. Peter Toth

139. Lipids: LDL, Cardiovascular Events, & Disparities in Care with Dr. Keith Ferdinand

143. Lipids: (Non)-Fasting LDL & Furious Lipid Lowering with Dr. Alison Bailey

156. Lipids: Triglycerides – Pathophysiology to Clinical Outcomes with Dr. Matthew Budoff

161. Triglycerides - Deep Dive into EPA and DHA with Dr. Erin Michos

179. Lipids: Polyunsaturated Fatty Acids, Omega-3 Fatty Acids, Eicosapentaenoic acid – Mechanisms of Action with Dr. Ty Gluckman

194. Lipids: Omega-3 Fatty Acids & The Battle Of The Oils with Dr. Pam Taub

207. Lipids: REDUCE-IT Versus STRENGTH Trials – EPA in Clinical Practice with Dr. Peter Toth

214. Lipids: Review of Icosapent Ethyl with Dr. Michael Shapiro